The reason is that overexpression of TPM1 may lead to DNA damage in tumor cells, which activates p53 expression, subsequently regulating Bcl-2 family members and finally promoting apoptosis of RCC cells through the mitochondrial pathway [27]. The gene discussed is TPM1; the disease is renal cell carcinoma.